003090.KS
Daewoong Co., Ltd. [003090.KS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
003090.KS Stock Summary
Top 10 Correlated ETFs
003090.KS
Top 10 Correlated Stocks
003090.KS
In the News
003090.KS Financial details
Company Rating
Buy
Market Cap
595.86B
Income
115.57B
Revenue
1783.01B
Book val./share
21278.58
Cash/share
9007.81
Dividend
100
Dividend %
0.64%
Employees
321
Optionable
No
Shortable
Yes
Earnings
13 Nov 2023
P/E
5.63
Forward P/E
-
PEG
1.21
P/S
0.36
P/B
0.74
P/C
1.74
P/FCF
12.63
Quick Ratio
1.04
Current Ratio
1.67
Debt / Equity
0.47
LT Debt / Equity
0.16
-
-
EPS (TTM)
2.78K
EPS next Y
-
EPS next Q
-
EPS this Y
28.91%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
28.69%
Revenue last 5Y
6.63%
Revenue Q/Q
7.7%
EPS Q/Q
-3.38%
-
-
-
-
SMA20
5.31%
SMA50
19.5%
SMA100
-1.31%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
14%
ROC
0.11%
Gross Margin
53%
Oper. Margin
10%
Profit Margin
6%
Payout
1%
Shs Outstand
41.58M
Shs Float
18.22M
-
-
-
-
Target Price
-
52W Range
11460.0-22150.0
52W High
-29.39%
52W Low
+36.47%
RSI
71
Rel Volume
5.12
Avg Volume
86.32K
Volume
441.73K
Perf Week
7.86%
Perf Month
12.36%
Perf Quarter
1.3%
Perf Half Y
7.42%
-
-
-
-
Beta
1.36469
-
-
Volatility
669.37%, 572.96%
Prev Close
0%
Price
15640
Change
3.1%
003090.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 28.53K | 31.63K | 32.28K | 36.38K | 40.43K | |
| Net income per share | 692 | 1.45K | 2.34K | 1.9K | 2.44K | |
| Operating cash flow per share | 1.05K | 3.21K | 3.46K | 3.21K | 3.55K | |
| Free cash flow per share | -502.74 | 1.62K | 1.91K | 425.23 | 749.26 | |
| Cash per share | 5.36K | 6.09K | 8.91K | 9.34K | 9.21K | |
| Book value per share | 13.2K | 14.53K | 16.32K | 17.58K | 19.74K | |
| Tangible book value per share | 18.74K | 19.77K | 22.17K | 22.27K | 23.92K | |
| Share holders equity per share | 13.2K | 14.53K | 16.32K | 17.58K | 19.74K | |
| Interest debt per share | 9.19K | 9.34K | 10.81K | 10.97K | 10.8K | |
| Market cap | 750.9B | 559.23B | 2112.02B | 1290.01B | 827.13B | |
| Enterprise value | 1042.62B | 885.19B | 2358.67B | 1610.88B | 1081.83B | |
| P/E ratio | 25.14 | 8.96 | 21.47 | 16.37 | 8.06 | |
| Price to sales ratio | 0.61 | 0.41 | 1.56 | 0.85 | 0.49 | |
| POCF ratio | 16.55 | 4.04 | 14.53 | 9.69 | 5.55 | |
| PFCF ratio | -34.61 | 7.97 | 26.31 | 73.02 | 26.29 | |
| P/B Ratio | 1.32 | 0.89 | 3.08 | 1.77 | 1 | |
| PTB ratio | 1.32 | 0.89 | 3.08 | 1.77 | 1 | |
| EV to sales | 0.85 | 0.65 | 1.74 | 1.07 | 0.64 | |
| Enterprise value over EBITDA | 6.87 | 5.78 | 11.76 | 9.26 | 4.82 | |
| EV to operating cash flow | 22.97 | 6.39 | 16.23 | 12.1 | 7.26 | |
| EV to free cash flow | -48.06 | 12.62 | 29.38 | 91.18 | 34.39 | |
| Earnings yield | 0.04 | 0.11 | 0.05 | 0.06 | 0.12 | |
| Free cash flow yield | -0.03 | 0.13 | 0.04 | 0.01 | 0.04 | |
| Debt to equity | 0.68 | 0.63 | 0.65 | 0.61 | 0.54 | |
| Debt to assets | 0.24 | 0.24 | 0.24 | 0.23 | 0.21 | |
| Net debt to EBITDA | 1.92 | 2.13 | 1.23 | 1.84 | 1.13 | |
| Current ratio | 1.92 | 2.69 | 2.27 | 1.65 | 1.85 | |
| Interest coverage | 8.94 | 10.65 | 14.25 | 11.99 | 24.83 | |
| Income quality | 1.39 | 1.94 | 1.23 | 1.33 | 1.24 | |
| Dividend Yield | 0.01 | 0.01 | 0 | 0.01 | 0.01 | |
| Payout ratio | 0.26 | 0.12 | 0.08 | 0.09 | 0.09 | |
| Sales general and administrative to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | |
| Research and developement to revenue | 0.11 | 0.09 | 0.09 | 0.09 | 0.1 | |
| Intangibles to total assets | 0.1 | 0.1 | 0.1 | 0.12 | 0.13 | |
| Capex to operating cash flow | -1.48 | -0.49 | -0.45 | -0.87 | -0.79 | |
| Capex to revenue | -0.05 | -0.05 | -0.05 | -0.08 | -0.07 | |
| Capex to depreciation | -1.14 | -1.37 | -1.28 | -2.28 | -2.44 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 14.34K | 21.74K | 29.33K | 27.39K | 32.94K | |
| ROIC | 0.05 | 0.09 | 0.11 | 0.09 | 0.13 | |
| Return on tangible assets | 0.02 | 0.04 | 0.06 | 0.05 | 0.05 | |
| Graham Net | -2.15K | -1.67K | -1.54K | -2.59K | -3.55K | |
| Working capital | 351.71B | 475.69B | 468.58B | 334.03B | 438.25B | |
| Tangible asset value | 808.82B | 853.57B | 931.06B | 925.44B | 1004.24B | |
| Net current asset value | 106.36B | 115.88B | 115.71B | 71.32B | 74.59B | |
| Invested capital | 0.68 | 0.63 | 0.65 | 0.61 | 0.54 | |
| Average receivables | 208.82B | 228.25B | 224.84B | 208.1B | 227.58B | |
| Average payables | 63.2B | 74.29B | 81.73B | 81.16B | 86.36B | |
| Average inventory | 268.05B | 268.5B | 251.52B | 251.12B | 283.42B | |
| Days sales outstanding | 63.46 | 64.8 | 55.81 | 50.46 | 52.95 | |
| Days payables outstanding | 34.62 | 41.74 | 39.91 | 40.3 | 41.23 | |
| Days of inventory on hand | 153.27 | 124.58 | 126.74 | 121.55 | 145.36 | |
| Receivables turnover | 5.75 | 5.63 | 6.54 | 7.23 | 6.89 | |
| Payables turnover | 10.54 | 8.74 | 9.14 | 9.06 | 8.85 | |
| Inventory turnover | 2.38 | 2.93 | 2.88 | 3 | 2.51 | |
| ROE | 0.05 | 0.1 | 0.14 | 0.11 | 0.12 | |
| Capex per share | -1.55K | -1.58K | -1.55K | -2.78K | -2.8K |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
| Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
|---|---|---|---|---|---|---|
| Revenue per share | 10.15K | 10.41K | 10.71K | 10.48K | 11.29K | |
| Net income per share | 770.22 | 935.65 | 26.82 | 924 | 892.6 | |
| Operating cash flow per share | 651.79 | 773.78 | 1.47K | 608.24 | 1.77K | |
| Free cash flow per share | 196.52 | -16.22 | 513.7 | -457.78 | 1.2K | |
| Cash per share | 9.64K | 9.13K | 9.31K | 8.66K | 9.01K | |
| Book value per share | 18.99K | 19.93K | 19.96K | 20.44K | 21.28K | |
| Tangible book value per share | 23.45K | 24.56K | 24.18K | 24.69K | 25.86K | |
| Share holders equity per share | 18.99K | 19.93K | 19.96K | 20.44K | 21.28K | |
| Interest debt per share | 10.58K | 11K | 10.81K | 10.75K | 9.95K | |
| Market cap | 1133B | 871.12B | 818.15B | 631.76B | 520.72B | |
| Enterprise value | 1393.15B | 1123.19B | 1072.85B | 855.7B | 732.53B | |
| P/E ratio | 8.84 | 5.6 | 183.61 | 4.11 | 3.51 | |
| Price to sales ratio | 2.68 | 2.01 | 1.84 | 1.45 | 1.11 | |
| POCF ratio | 41.81 | 27.07 | 13.44 | 24.97 | 7.07 | |
| PFCF ratio | 138.67 | -1.29K | 38.35 | -33.18 | 10.44 | |
| P/B Ratio | 1.43 | 1.05 | 0.99 | 0.74 | 0.59 | |
| PTB ratio | 1.43 | 1.05 | 0.99 | 0.74 | 0.59 | |
| EV to sales | 3.3 | 2.6 | 2.41 | 1.96 | 1.56 | |
| Enterprise value over EBITDA | 19.75 | 16.04 | 62.68 | 13.99 | 1.56 | |
| EV to operating cash flow | 51.41 | 34.91 | 17.63 | 33.83 | 9.95 | |
| EV to free cash flow | 170.5 | -1.67K | 50.29 | -44.94 | 14.69 | |
| Earnings yield | 0.03 | 0.04 | 0 | 0.06 | 0.07 | |
| Free cash flow yield | 0.01 | 0 | 0.03 | -0.03 | 0.1 | |
| Debt to equity | 0.56 | 0.54 | 0.54 | 0.52 | 0.47 | |
| Debt to assets | 0.22 | 0.21 | 0.21 | 0.2 | 0.18 | |
| Net debt to EBITDA | 3.69 | 3.6 | 14.88 | 3.66 | 0.45 | |
| Current ratio | 2.04 | 1.96 | 1.85 | 1.8 | 1.67 | |
| Interest coverage | -15.72 | 5.16 | 1.19 | 11.14 | 0 | |
| Income quality | 0.68 | 0.65 | 54.64 | 0.57 | 1.38 | |
| Dividend Yield | 0.01 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0.23 | 0 | 0.76 | 0 | 0 | |
| Sales general and administrative to revenue | 0.02 | 0.02 | 0.02 | 0.04 | 0.85 | |
| Research and developement to revenue | 0.1 | 0.09 | 0.11 | 0.04 | 0.02 | |
| Intangibles to total assets | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | |
| Capex to operating cash flow | -0.7 | -1.02 | -0.65 | -1.75 | -0.32 | |
| Capex to revenue | -0.04 | -0.08 | -0.09 | -0.1 | -0.05 | |
| Capex to depreciation | -1.68 | -2.84 | -3.12 | -3.27 | -1.83 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 18.14K | 20.48K | 3.47K | 20.61K | 20.67K | |
| ROIC | 0.04 | 0.03 | 0 | 0.03 | 0.04 | |
| Return on tangible assets | 0.02 | 0.02 | 0 | 0.02 | 0.02 | |
| Graham Net | -2.56K | -3.18K | -3.59K | -4.39K | -3.9K | |
| Working capital | 468.57B | 450.69B | 438.25B | 416.62B | 382.34B | |
| Tangible asset value | 974.83B | 1021.18B | 1004.24B | 1027.05B | 1075.58B | |
| Net current asset value | 112.06B | 95.96B | 74.59B | 62.59B | 81.75B | |
| Invested capital | 0.56 | 0.54 | 0.54 | 0.52 | 0.47 | |
| Average receivables | 202.8B | 210.14B | 228.19B | 234.24B | 219.57B | |
| Average payables | 92.52B | 99.25B | 97.37B | 95.43B | 96.92B | |
| Average inventory | 274.88B | 301.39B | 316.23B | 327.27B | 337.51B | |
| Days sales outstanding | 44.8 | 43.7 | 49.8 | 45.9 | 41.58 | |
| Days payables outstanding | 43.33 | 46.77 | 38.83 | 43.12 | 39.08 | |
| Days of inventory on hand | 132.96 | 140.7 | 136.9 | 144.18 | 141.96 | |
| Receivables turnover | 2.01 | 2.06 | 1.81 | 1.96 | 2.16 | |
| Payables turnover | 2.08 | 1.92 | 2.32 | 2.09 | 2.3 | |
| Inventory turnover | 0.68 | 0.64 | 0.66 | 0.62 | 0.63 | |
| ROE | 0.04 | 0.05 | 0 | 0.05 | 0.04 | |
| Capex per share | -455.27 | -790 | -951.86 | -1.07K | -571.29 |
003090.KS Frequently Asked Questions
What is Daewoong Co., Ltd. stock symbol ?
Daewoong Co., Ltd. is a KR stock and trading under the symbol 003090.KS
What is Daewoong Co., Ltd. stock quote today ?
Daewoong Co., Ltd. stock price is $15640 today.
Is Daewoong Co., Ltd. stock public?
Yes, Daewoong Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 86.32K
- Market Capitalization 595.86B
- Employee 321
- CEO Mr. Yeong-Hwan Yoon
- Headquarters Hwaseong-si,KR
- IPO Date 2000-01-04
-
Website
https://www.daewoongholdings.com 
Daewoong Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceuticals. It also engages in the leasing of real estates. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1961 and is headquartered in Seongnam-si, South Korea.
